Covered recipient · General Payments record
STEVEN THOMAS O'DONNELL
Allopathic & Osteopathic Physicians Neuromusculoskeletal Medicine & OMM
General Payments · PY2018–2024
$2,742.62
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $450.62 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $165.49 | 10 |
| Lilly USA, LLC | $120.92 | 6 |
| Acerta Pharma LLC | $53.36 | 3 |
| PFIZER INC. | $34.94 | 2 |
| Amgen Inc. | $21.00 | 1 |
| ABBVIE INC. | $20.29 | 1 |
| Exact Sciences Corporation | $17.82 | 1 |
| Abbott Laboratories | $16.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.80 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125337778 | CMS |
| ABBVIE INC. | $20.29 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105139360 | CMS |
| Amgen Inc. | $21.00 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115978076 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.96 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105376307 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.00 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104216713 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.40 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105324871 | CMS |
| Exact Sciences Corporation | $17.82 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114813219 | CMS |
| Lilly USA, LLC | $20.15 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135393135 | CMS |
| Lilly USA, LLC | $20.04 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135433241 | CMS |
| Lilly USA, LLC | $19.92 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135434497 | CMS |
| Lilly USA, LLC | $28.18 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135407793 | CMS |
| Lilly USA, LLC | $16.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135351048 | CMS |
| Lilly USA, LLC | $16.26 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135433243 | CMS |
| Novo Nordisk Inc | $11.13 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096575431 | CMS |
| Novo Nordisk Inc | $18.86 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096622944 | CMS |
| Novo Nordisk Inc | $15.86 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096713339 | CMS |
| Novo Nordisk Inc | $19.54 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096838680 | CMS |
| Novo Nordisk Inc | $19.24 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097050649 | CMS |
| Novo Nordisk Inc | $12.25 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097553311 | CMS |
| Novo Nordisk Inc | $17.49 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096929590 | CMS |
| Novo Nordisk Inc | $23.87 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097056445 | CMS |
| Novo Nordisk Inc | $16.77 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097449564 | CMS |
| Novo Nordisk Inc | $10.48 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097397048 | CMS |
| PFIZER INC. | $14.49 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131250604 | CMS |
| PFIZER INC. | $20.45 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131494432 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.